-
Disease-modifying drug reduces brain protein plaques in Alzheimer patients
Madely Health Headlines Commentary for March 1, 2010 [display_podcast] Source: Neuroimaging technique shows potential of bapineuzumab treatment and might be useful in assessing other drugs for Alzheimer’s Disease Reference: 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer’s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study